A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision

Ji Won Lim; Kyeong-Ik Na
March 2011
Indian Journal of Ophthalmology;Mar2011, Vol. 59 Issue 2, p93
Academic Journal
Aim: To compare the effect of intravitreal bevacizumab and triamcinolone in patients with macular edema after central retinal vein occlusion (CRVO), presenting with poor visual acuity. Materials and Methods: It was a retrospective, comparative case series of 38 consecutive eyes, with macular edema secondary to CRVO, with 20/200 or worse vision, which were treated primarily either with intravitreal bevacizumab (1.25 mg; 24 eyes) or intravitreal triamcinolone (4 mg; 14 eyes). During follow-up, 3.6 ± 0.8 re-injections of bevacizumab and 2.4 ± 0.5 re-injections of triamcinolone were administered (P = 0.080). The main outcome measures were the best-corrected visual acuity and the central macular thickness by optical coherence tomography during 12 months of follow-up. Results: At 12 months, visual acuity (logMAR) was changed from 1.03 ± 0.39 (baseline) to 0.92 ± 0.39 (P = 0.374) and the central macular thickness was reduced from a baseline of 713.6 ± 179.3 μm to 310.8 ± 205.2 μm (P = 0.000). Neither the bevacizumab nor triamcinolone groups varied significantly in visual acuity and central macular thickness at 1, 3, 6, and 12 months after treatment. Neovascular glaucoma developed in two of the 14 eyes (14%) in the triamcinolone group. Conclusion: In patients with CRVO and poor vision, intravitreal bevacizumab and intravitreal triamcinolone were associated with a reduction in macular edema; however, neither treatment achieved significant visual acuity improvement by the 12-month follow-up.


Related Articles

  • Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Refractory Diffuse Diabetic Macular Edema. Dehghan, Mohammad-Hossein; Salehipour, Masoud; Naghib, Jalil; Babaeian, Mahnaz; Karimi, Saeed; Yaseri, Mehdi // Journal of Ophthalmic & Vision Research;Jul2010, Vol. 5 Issue 3, p162 

    Purpose: To evaluate the effect of pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling for management of refractory diffuse diabetic macular edema (DME). Methods: In this prospective interventional case series, eyes with refractory diffuse DME unresponsive to macular...

  • Optical coherence tomography in progressive cone dystrophy. Zahlava, Jiri; Lestak, Jan; Karel, Ivan // Biomedical Papers of the Medical Faculty of Palacky University i;Dec2014, Vol. 158 Issue 4, p628 

    Aim. The aim of the study was to analyse different clinical pictures in patients with progressive cone dystrophy (PCD), to compare these with the results of optical coherence tomography (OCT) and to evaluate the benefits of this method for diagnosis. Methods. The group consisted of 16 patients...

  • Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema. Böhm, Michael; Uhlig, Constantin // Graefe's Archive of Clinical & Experimental Ophthalmology;Jul2011, Vol. 249 Issue 7, p1099 

    Background: Intravitreal application of triamcinolone and bevacizumab in Coats' disease with macular edema to improve visual outcome. Methods: Testing of best-corrected visual acuity (BCVA), ophthalmoscopy, optical coherence tomography, fluorescein angiography, 30° perimetry, and full-field...

  • Retinal Pigment Epithelial Tear Following Bevacizumab For Exudative Age-Related Macular Degeneration: An OCT Follow-Up. Çakir, Mehmet; Çekiç, Osman; Yilmaz, Ö. Faruk // Retina-Vitreus/Journal of Retina-Vitreous;Dec2009, Vol. 17 Issue 4, p288 

    We report a case of retinal pigment epithelial (RPE) tear occurred after intravitreal bevacizumab injection for serous pigment epithelial detachment (PED) from neovascular age-related macular degeneration. An 80-year-old woman who underwent 1.25 mg intravitreal bevacizumab treatment for serous...

  • Effect of Intravitreal Bevacizumab (Avastin®) Therapy in Malignant Hypertensive Retinopathy: A Report of Two Cases. Kim, Eui Yon; Lew, Ho Min; Song, Ji Hun // Journal of Ocular Pharmacology & Therapeutics;Jun2012, Vol. 28 Issue 3, p318 

    Purpose: Malignant hypertensive retinopathy is a rare, but serious, complication of uncontrolled systemic hypertension for which no treatment has been established yet. We report 2 patients with malignant hypertensive retinopathy who recovered promptly following intravitreal bevacizumab...

  • Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization. Milani, Paolo; Massacesi, Amedeo; Ciaccia, Stefano; Setaccioli, Marco; Moschini, Stefania; Bergamini, Fulvio // Clinical Ophthalmology;2012 Part 2, Vol. 6, p1885 

    Background: The aim of this study was to evaluate the efficacy of intravitreal bevacizumab when administered on an as-needed basis for the treatment of myopic choroidal neovascularization (CNV), and to assess visual changes upon treatment. Methods: This study was designed as a retrospective,...

  • Akut Santral Seröz Koryoretinopati Olgularında, Vasküler Endotelyal Büyüme Faktörü Ä°nhibitör Tedavisinin EtkinliÄŸi. Teke, Mehmet Yasin; Şen, Emine; Elgin, Ufuk; Özdal, Pınar; Öztürk, Faruk // Retina-Vitreus/Journal of Retina-Vitreous;Jun2012, Vol. 20 Issue 2, p111 

    Purpose: To determine the effect of intravitreal bevacizumab (IVB) injection on visual acuity and central macular thickness (CMT) values in acute central serous chorioretinopathy (CSR) cases. Materials and Methods: 30 eyes of 30 cases with acute CSR, who had undergone one injection of IVB...

  • Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia. Takayama, K.; Ooto, Ohoto S.; Tamura, H.; Yamashiro, K.; Otani, A.; Tsujikawa, A.; Yoshimura, N // Eye;Sep2010, Vol. 24 Issue 9, p1492 

    PurposeTo evaluate the effect of intravitreal bevacizumab injection for treating type 1 idiopathic macular telangiectasia (IMT).MethodsRetrospective case series of five eyes of five male patients with type 1 IMT that were treated with 2–3 injections of intravitreal bevacizumab....

  • Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion. Eltutar, Kadir; Acar, Fahreddin; Dincer, Nurhan; Zirtiloglu, Sibel; Unsal, Erkan // Clinical Ophthalmology;2013, Vol. 7, p1777 

    Background: The purpose of this study was to evaluate the effects of intravitreal bevacizumab injection in the treatment of macular thickness and reduced visual acuity in patients with branch retinal vein occlusion. Methods: In this retrospective study, we evaluated 15 eyes of 15 consecutive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics